33.78 +1.77 (5.53%)
Pre-Market: 9:09AM EDT
|Bid||33.52 x 1100|
|Ask||33.65 x 800|
|Day's Range||30.30 - 32.88|
|52 Week Range||16.74 - 32.88|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
SMITHS FALLS, ON, June 20, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") announced today the closing of its previously announced offering of C$500 million aggregate principal amount of its 4.25% convertible senior notes due 2023 (the "notes"). The initial conversion rate for the notes is 20.7577 common shares ("common shares") per C$1,000 principal amount of the notes, equivalent to an initial conversion price of approximately C$48.18 per share. The Company intends to use the net proceeds from the sale of the notes for supporting expansion initiatives and general corporate purposes, including working capital requirements.
NEW YORK, NY / ACCESSWIRE / June 20, 2018 / As Canada officially legalized recreational marijuana this week, shares of Canopy Growth skyrocketed after announcing a multi-year agreement with Neptune Technologies & Bioressources Inc. Shares of GW Pharmaceuticals were modestly in the red despite any news. Canopy Growth Corporation shares closed up almost 4% on Tuesday with nearly 4.5 million shares traded. The stock hit a brand new high of $32.88 yesterday after it was revealed that Neptune Technologies & Bioressources Inc. has entered into a multi-year agreement with Canopy Growth to supplement Canopy Growth's extraction, refinement, and extract product formulation capacity.
China’s Nuclear Option: Stop Buying US Treasuries Bloomberg is floating the idea this morning that all China must needs to win the burgeoning trade war with the US is stop loaning the US money. This is called the “nuclear option” apparently, though it literally requires no action at all. Bloomberg also has its eyes on […] The post Market Morning: Chinese US Investment Collapses, Canadian Cannabis, GE Gets DOWnsized appeared first on Market Exclusive.
LAVAL, QC, June 19, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT - News) (TSX:NEPT.TO - News), today announced that it entered into a multi-year agreement with Canopy Growth (TSX:WEED.TO - News) (NYSE:CGC - News). Under the terms of the agreement, Neptune will supplement Canopy Growth's extraction, refinement, and extract product formulation capacity. "We are truly excited to partner with such a great company as Canopy Growth.
NEW YORK, NY / ACCESSWIRE / June 18, 2018 / U.S. market plunged on Friday, but well-off session lows as investors appeared to look at previous signs of escalating trade tension between Washington and Beijing. ...
SMITHS FALLS, ON, June 18, 2018 /CNW/ - Spectrum Cannabis ("Spectrum Cannabis"), the global medical subsidiary of Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) is proud to announce the introduction of convenient, colour-coded Softgels to its product line in Canada.
SMITHS FALLS, ON, June 15, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") announced today that it has priced its previously announced offering of convertible senior notes due 2023 (the "notes"). The Company will issue C$500 million aggregate principal amount of the notes. Canopy Growth has granted the initial purchasers of the notes an option to purchase up to an additional C$100 million aggregate principal amount of notes.
NEW YORK, June 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy ...
Aurora Cannabis Inc. (TSX:ACB) is at it again with the acquisitions. Here's what investors need to know.
Yesterday, Canopy Growth (CGC) (WEED) announced that it plans to release its earnings on June 27 for its fiscal fourth quarter and fiscal year, which ended on March 31. In its press release, Canopy Growth also offered a preview of what to expect from its results. The company stated that it expects revenues to be between 22.5 million and 23 million Canadian dollars for the quarter compared to 14.7 million Canadian dollars a year ago, an increase of 53% to 56%.
Bitcoin Untethered, Literally Speculation is mounting that the price of bitcoin (BTC-USD) and other altcoins like ethereum (ETH-USD) and bitcoin cash (BCH-USD) has been manipulated using a scheme pretty much identical to what the Federal Reserve uses to inflate the price of US treasuries. Tether (USDT-USD), a crytpocurrency token supposedly backed by, or “tethered” to […] The post Market Morning: Bitcoin Untethered, Fed Talks Marijuana, Whole Amazon Foods Clash appeared first on Market Exclusive.
SMITHS FALLS, ON, June 13, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") will release its financial results for the fourth quarter and fiscal year ended March 31, 2018 on June 27, 2018. Following the release of its fourth quarter and fiscal year 2018 financial results, Canopy Growth will host a conference call and audio webcast with Bruce Linton, Chairman and Chief Executive Officer, and Tim Saunders, Executive Vice-President and Chief Financial Officer, at 8:30 am Eastern Time the same day. The Company also announced that, based upon information currently available to management, it anticipates reporting revenue of between $22.5 million and $23 million for the quarter ended March 31, 2018, compared to approximately $14.7 million for the quarter ended March 31, 2017.
SMITHS FALLS, ON, June 13, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") announced today that it proposes to offer C$400.0 million aggregate principal amount of convertible senior notes due 2023 (the "notes"), subject to market conditions and other factors. The notes will be sold to accredited investors in Canada pursuant to an exemption from the prospectus requirements of Canadian securities laws. Canopy Growth also intends to grant to the initial purchasers of the notes an option to purchase up to an additional C$60.0 million aggregate principal amount of notes. Canopy Growth has been advised by Greenstar Canada Investment Limited Partnership, an affiliate of Constellation Brands, Inc., that it intends to participate in the offering.
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and other pot stocks could see tremendous growth opportunities once the U.S. legalizes pot.
NEW YORK, NY / ACCESSWIRE / June 13, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Canopy Growth Corp (CGC), a licensed cannabis producer. CGC already has commercial operations up and running, with well-diversified operations in eight countries, including Canada and having a licensed domestic growing platform of 2.4 million sq. ft. CGC recently announced its listing on the New York Stock Exchange and has become the first publicly traded federally regulated cannabis company in North America, and the first to be included in the S&P/TSX Composite index.
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) are just two of three explosive stocks that could give your portfolio the market-beating edge it needs over the next year.
SMITHS FALLS, ON, June 12, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) (the "Company" or "Canopy Growth") is pleased to provide the following updates on its medical cannabis program and to re-affirm its strong commitment to medical cannabis, the patients who depend on it, and the Healthcare Professionals who prescribe it. Marking a major milestone for medical cannabis in Canada, a Phase IIb "in-human" clinical trial application was submitted by Canopy Health Innovations Inc. to evaluate the use of medical cannabis in the treatment of insomnia.
SMITHS FALLS, ON, June 11, 2018 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) and its subsidiary, Bedrocan Canada Inc. ("BC") are pleased to announce that they have reached an agreement (the "Agreement") with Bedrocan International BV ("BI") (together, the "Parties") to bring the Parties' licensing arrangement to a close. Canopy Growth will retain the licensed production facility, licensed sales facility, and all associated licenses owned and operated by BC. Management will redeploy these facilities, free of the current royalty structure and fixed production practices, to develop new premium branded cannabis offerings.
Last week was one of the most important weeks for the cannabis sector, as Canada’s Senate approved Bill C-45, which is also known as the “Cannabis Act.” The approval of this bill was the most critical hurdle to overcome for the cannabis sector. Read more at Canada’s Senate Approves Cannabis Act: Positive for Investors. Most of the sector ETFs were broadly positive last week.
Don't worry that most marijuana stocks fell after the big Canadian Senate vote on Thursday. These three stocks should be winners over the long run.
Trade tensions loom large at the weekend G7 meetings, but investors should not turn their backs on stocks like Dollarama Inc. (TSX:DOL) just yet.
The growth of the European market should signal investors to stick with stocks like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) long term.